Depressive Symptoms and Associated Clinical Characteristics in Outpatients Seeking Community-Based Treatment for Alcohol and Drug Problems

REFERENCES

• Nunes EV, Levin FR. Treating depression in substance abusers. Curr Psychiatry Rep. 2006;8:363–370.
   PubMedGoogle Scholar
• Dakwar E, Nunes EV, Bisaga A, et al. A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. Am J Addict. 2011;20:441–446.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder —results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–3105.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry. 1996;168:17–30.
   Web of Science ®Google Scholar
• Grant BF. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J Subst Use. 1995;7:481–497.
   Google Scholar
• Nunes EV, Weiss RD. Co-occurring addiction and affective disorders. In: Ries RK, Fiellin DA, Miller SC, Saitz R, eds. Principles of Addiction Medicine. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:1151–1182.
   Google Scholar
• Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States—results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64:566–576.
   PubMed Web of Science ®Google Scholar
• Davis LL, Pilkinton P, Wisniewski SR, et al. Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial. Depress Anxiety. 2012;29:111–122.
   PubMed Web of Science ®Google Scholar
• Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence—a meta-analysis. JAMA. 2004;291:1887–1896.
   PubMed Web of Science ®Google Scholar
• Compton WM, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry. 2003;160:890–895.
   PubMed Web of Science ®Google Scholar
• Hasin D, Kilcoyne B. Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC. Curr Opin Psychiatry. 2012;25:165–171.
   PubMed Web of Science ®Google Scholar
• Hepner KA, Hunter SB, Edelen MO, Zhou AJ, Watkins K. A comparison of two depressive symptomatology measures in residential substance abuse treatment clients. J Subst Abuse Treat. 2009;37:318–325.
   PubMed Web of Science ®Google Scholar
• Dum M, Pickren J, Sobell LC, Sobell MB. Comparing the BDI-II and the PHQ-9 with outpatient substance abusers. Addict Behav. 2008;33:381–387.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Higgins ST. Therapy Manuals for Drug Addiction, A Community Reinforcement Plus Vouchers Approach: Treating Cocaine Addiction. Rockville, MD: National Institute on Drug Abuse; 1998.
   Google Scholar
• Petry NM, Peirce JM, Stitzer ML, et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs—a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry. 2005;62:1148–1156.
   PubMed Web of Science ®Google Scholar
• Stitzer ML, Petry NM, Peirce J. Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network. J Subst Abus Treat. 2010;38:S61–S69.
   PubMed Web of Science ®Google Scholar
• Bickel WK, Marsch LA, Buchhalter AR, Badger GJ. Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Exp Clin Psychopharmacol. 2008;16:132–143.
   PubMed Web of Science ®Google Scholar
• Campbell ANC, Nunes EV, Miele GM, et al. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials. 2012;33:386–395.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 Study. JAMA. 1994;272:1749–1756.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self-report version of PRIME-MD—the PHQ primary care study. JAMA. 1999;282:1737–1744.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32:509–515.
   Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JBW. The PHQ-9—validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613.
   PubMed Web of Science ®Google Scholar
• Litt MD, Kadden RM, Cooney NL, Kabela E. Coping skills and treatment outcomes in cognitive-behavioral and interactional group therapy for alcoholism. J Consult Clin Psychol. 2003;71:118–128.
   PubMed Web of Science ®Google Scholar
• McWilliams LA, Cox BJ, Enns MW. Use of the Coping Inventory for Stressful Situations in a clinically depressed sample: factor structure, personality correlates, and prediction of distress. J Clin Psychol. 2003;59:1371–1385.
   Web of Science ®Google Scholar
• DeLongis A, Holtzman S. Coping in context: the role of stress, social support, and personality in coping. J Pers. 2005;73:1633–1656.
   PubMed Web of Science ®Google Scholar
• Vitaliano PP, Maiuro RD, Russo J, Becker J. Raw versus relative scores in the assessment of coping strategies. J Behav Med. 1987;10:1–18.
   PubMed Web of Science ®Google Scholar
• Weissman MM, Prusoff BA, Thompson WD, Harding PS, Myers JK. Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis. 1978;166:317–326.
   PubMed Web of Science ®Google Scholar
• EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
   PubMed Web of Science ®Google Scholar
• Sobell LC, Sobell MB. Timeline Follow-back: a technique for assessing self-reported ethanol consumption. In: Allen J, Litten RZ, eds. Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa, NJ: Humana Press; 1992:41–72.
   Google Scholar
• Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States—results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64:830–842.
   PubMed Web of Science ®Google Scholar
• Cohen P, Cohen J. The clinician's illusion. Arch Gen Psychiatry. 1984;41:1178–1182.
   PubMed Web of Science ®Google Scholar
• Goldberg D, Fawcett J. The importance of anxiety in both major depression and bipolar disorder. Depress Anxiety. 2012;29:471–478.
   PubMed Web of Science ®Google Scholar
• Andrews G, Anderson TM, Slade T, Sunderland M. Classification of anxiety and depressive disorders: problems and solutions. Depress Anxiety. 2008;25:274–281.
   PubMed Web of Science ®Google Scholar
• Howland RH, Rush AJ, Wisniewski SR, et al. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug Alcohol Depend. 2009;99:248–260.
   PubMed Web of Science ®Google Scholar
• Brady KT, Haynes LF, Hartwell KJ, Killeen TK. Substance use disorders and anxiety: a treatment challenge for social workers. Soc. Work Public Health. 2013;28:407–423.
   PubMed Web of Science ®Google Scholar
• Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67:247–257.
   PubMed Web of Science ®Google Scholar
• Bizzarri JV, Rucci P, Sbrana A, et al. Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders. Addict Behav. 2007;32:384–391.
   PubMed Web of Science ®Google Scholar
• Thornton LK, Baker AL, Lewin TJ, et al. Reasons for substance use among people with mental disorders. Addict Behav. 2012;37:427–434.
   PubMed Web of Science ®Google Scholar
• Grant VV, Stewart SH, Mohr CD. Coping-anxiety and coping-depression motives predict different daily mood-drinking relationships. Psychol Addict Behav. 2009;23:226–237.
   PubMed Web of Science ®Google Scholar
• Dolan SL, Rohsenow DJ, Martin RA, Monti PM. Urge-specific and lifestyle coping strategies of alcoholics: relationships of specific strategies to treatment outcome. Drug Alcohol Depend. 2013;128:8–14.
   PubMed Web of Science ®Google Scholar
• Walters ST, Ondersma SJ, Ingersoll KS, et al. MAPIT: development of a Web-based intervention targeting substance abuse treatment in the criminal justice system. J Subst Abuse Treat. 2014;46:60–65.
   PubMed Web of Science ®Google Scholar